Diagnosis of Intracranial Hypertension Using TCCD, ONSD and ODH by Bedside Ultrasound

NCT ID: NCT07151287

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-15

Study Completion Date

2027-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to investigate several means of measuring intracranial pressure (ICP) non-invasively in patients who had head trauma and received implantation of invasive ICP monitor device. The main questions it aims to answer are:

What are the diagnostic efficacies of Transcranial Color-Coded Doppler Ultrasound (TCCD), Optic Nerve Sheath Diameter (ONSD) and Optic Disc Height (ODH) (the 3 non-invasive way of measuring ICP) compared with invasive ICP monitor? Participants will receive simultaneous non-invasive measurements of TCCD, ONSD and ODH along with during the days of invasive ICP monitoring. The data will be compared among the techniques to study the diagnostic efficacy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with traumatic brain injury and invasive ICP monitoring

Patients with traumatic brain injury and invasive ICP monitoring.

TCCD

Intervention Type DIAGNOSTIC_TEST

Patients receive non-invasive assessments of TCCD using bedside ultrasound.

ONSD

Intervention Type DIAGNOSTIC_TEST

Patients receive non-invasive assessments of ONSD using bedside ultrasound.

ODH

Intervention Type DIAGNOSTIC_TEST

Patients receive non-invasive assessments of ODH using bedside ultrasound.

Invasive ICP

Intervention Type DIAGNOSTIC_TEST

Patients receive invasive assessments of ICP.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TCCD

Patients receive non-invasive assessments of TCCD using bedside ultrasound.

Intervention Type DIAGNOSTIC_TEST

ONSD

Patients receive non-invasive assessments of ONSD using bedside ultrasound.

Intervention Type DIAGNOSTIC_TEST

ODH

Patients receive non-invasive assessments of ODH using bedside ultrasound.

Intervention Type DIAGNOSTIC_TEST

Invasive ICP

Patients receive invasive assessments of ICP.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Traumatic brain injury;
* Received invasive ICP monitoring;
* age ≥ 18 years old.

Exclusion Criteria

* Severe eyeball / eyelid damage prevents transorbital ultrasound examination;
* Allergy to ultrasound coupling agent;
* Pregnant or lactating females.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xiangya Hospital of Central South University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jinfang Liu, MD

Director of the Neurotrauma and Neurointensive Care Group

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ziyuan Liu, M.D.

Role: CONTACT

86-151-1137-3960

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ultrasound-ICP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.